Northwest Biotherapeutics Inc (NWBO)

Currency in USD
0.240
-0.014(-5.52%)
Closed·
0.243+0.003(+1.25%)
·
NWBO Scorecard
Full Analysis
Suffers from weak gross profit margins
NWBO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2350.255
52 wk Range
0.1680.479
Key Statistics
Prev. Close
0.24
Open
0.255
Day's Range
0.235-0.255
52 wk Range
0.168-0.479
Volume
2.43M
Average Volume (3m)
2.36M
1-Year Change
-30.8%
Book Value / Share
-0.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NWBO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Northwest Biotherapeutics Inc Company Profile

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inoperable solid tumors, as well as a range of types of cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Compare NWBO to Peers and Sector

Metrics to compare
NWBO
Peers
Sector
Relationship
P/E Ratio
−4.5x−2.7x−0.6x
PEG Ratio
−0.46−0.040.00
Price/Book
−3.8x2.4x2.6x
Price / LTM Sales
344.2x6.9x3.3x
Upside (Analyst Target)
-334.8%40.1%
Fair Value Upside
Unlock5.1%5.3%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
131.00K / --
EPS Revisions
Last 90 days

NWBO Income Statement

People Also Watch

20.18
SRPT
-3.86%
0.483
WINT
-0.41%
6.740
AMPX
-6.52%
49.78
BMNR
-9.28%
3.170
VTGN
-6.76%

FAQ

What Stock Exchange Does Northwest Biotherapeutics Trade On?

Northwest Biotherapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Northwest Biotherapeutics?

The stock symbol for Northwest Biotherapeutics is "NWBO."

What Is the Northwest Biotherapeutics Market Cap?

As of today, Northwest Biotherapeutics market cap is 358.73M.

What Is Northwest Biotherapeutics's Earnings Per Share (TTM)?

The Northwest Biotherapeutics EPS (TTM) is -0.06.

From a Technical Analysis Perspective, Is NWBO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Northwest Biotherapeutics Stock Split?

Northwest Biotherapeutics has split 2 times.

How Many Employees Does Northwest Biotherapeutics Have?

Northwest Biotherapeutics has 25 employees.

What is the current trading status of Northwest Biotherapeutics (NWBO)?

As of 20 Aug 2025, Northwest Biotherapeutics (NWBO) is trading at a price of 0.24, with a previous close of 0.24. The stock has fluctuated within a day range of 0.24 to 0.26, while its 52-week range spans from 0.17 to 0.48.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.